CAS: 1025796-31-9 - 1,5-Bis(1,1-dimethylethyl) N-[[[(1S)-5-amino-1-[(1,1-dimethylethoxy)carbonyl]pentyl]amino]carbonyl]-L-glutamate
Formula:C24H45N3O7
InChI:InChI=1S/C24H45N3O7/c1-22(2,3)32-18(28)14-13-17(20(30)34-24(7,8)9)27-21(31)26-16(12-10-11-15-25)19(29)33-23(4,5)6/h16-17H,10-15,25H2,1-9H3,(H2,26,27,31)/t16-,17-/m0/s1
InChI key:InChIKey=IXWXFSGSTGXUFO-IRXDYDNUSA-N
SMILES:O=C(NC(C(=O)OC(C)(C)C)CCC(=O)OC(C)(C)C)NC(C(=O)OC(C)(C)C)CCCCN
- Synonyms:
- 1,5-Bis(1,1-dimethylethyl) N-[[[(1S)-5-amino-1-[(1,1-dimethylethoxy)carbonyl]pentyl]amino]carbonyl]-L-glutamate
- L-Glutamic acid, N-[[[(1S)-5-amino-1-[(1,1-dimethylethoxy)carbonyl]pentyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester
- Di-tert-butyl (((S)-6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)carbamoyl)-L-glutamate
L-Glutamic acid, N-[[[(1S)-5-amino-1-[(1,1-dimethylethoxy)carbonyl]pentyl]amino]carbonyl]-, 1,5-bis(1,1-dimethylethyl) ester
CAS:1025796-31-9
Formula:
C24H45N3O7
Purity:
95%
Color and Shape:
Solid
Molecular weight:
487.6300
Ref: IN-DA0007SQ
1g | 482.00 € | ||
5g | To inquire | ||
10g | To inquire | ||
25g | To inquire | ||
100mg | 120.00 € | ||
250mg | 151.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
(S)-di-tert-Butyl 2-(3-((S)-6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)ureido)pentanedioate
CAS:1025796-31-9
Purity:
95%
Molecular weight:
487.63800048828125
Ref: 10-F602355
1g | 383.00 € | ||
5g | 1,194.00 € | ||
100mg | 93.00 € | ||
250mg | 129.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
CS-0047390
CAS:1025796-31-9
CS-0047390 ((S)-Di-tert-butyl 2-(3-((S)-6-amino-1-(tert-butoxy)-1-oxohexan-2-yl)ureido)pentanedioate), also known as tert-Butyl-DCL, is a PSMA inhibitor and a
Formula:
C24H45N3O7
Purity:
≥98%
Color and Shape:
Solid
Molecular weight:
487.63
Ref: TM-T9280
50mg | 39.00 € | ||
1mL*10mM (DMSO) | 46.00 € |
Estimated delivery in United States, on Monday 13 Jan 2025
(S)-Di-tert-butyl 2-(3-((S)-6-Amino-1-(tert-butoxy)-1-oxohexan-2-yl)ureido)pentanedioate
CAS:1025796-31-9
(S)-Di-tert-butyl 2-(3-((S)-6-Amino-1-(tert-butoxy)-1-oxohexan-2-yl)ureido)pentanedioate is a potential drug for the treatment of prostate cancer. It has been …
Formula:
C24H45N3O7
Purity:
Min. 95%
Molecular weight:
487.63 g/mol
Ref: 3D-ARB79631
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025